These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 15102928

  • 1. Development of bombesin analogs with conformationally restricted amino acid substitutions with enhanced selectivity for the orphan receptor human bombesin receptor subtype 3.
    Mantey SA, Coy DH, Entsuah LK, Jensen RT.
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1161-70. PubMed ID: 15102928
    [Abstract] [Full Text] [Related]

  • 2. Systematic optimization of a lead-structure identities for a selective short peptide agonist for the human orphan receptor BRS-3.
    Weber D, Berger C, Heinrich T, Eickelmann P, Antel J, Kessler H.
    J Pept Sci; 2002 Aug; 8(8):461-75. PubMed ID: 12212809
    [Abstract] [Full Text] [Related]

  • 3. Ability of various bombesin receptor agonists and antagonists to alter intracellular signaling of the human orphan receptor BRS-3.
    Ryan RR, Weber HC, Hou W, Sainz E, Mantey SA, Battey JF, Coy DH, Jensen RT.
    J Biol Chem; 1998 May 29; 273(22):13613-24. PubMed ID: 9593699
    [Abstract] [Full Text] [Related]

  • 4. Pharmacology and cell biology of the bombesin receptor subtype 4 (BB4-R).
    Katsuno T, Pradhan TK, Ryan RR, Mantey SA, Hou W, Donohue PJ, Akeson MA, Spindel ER, Battey JF, Coy DH, Jensen RT.
    Biochemistry; 1999 Jun 01; 38(22):7307-20. PubMed ID: 10353842
    [Abstract] [Full Text] [Related]

  • 5. Discovery of high affinity bombesin receptor subtype 3 agonists.
    Wu JM, Nitecki DE, Biancalana S, Feldman RI.
    Mol Pharmacol; 1996 Nov 01; 50(5):1355-63. PubMed ID: 8913368
    [Abstract] [Full Text] [Related]

  • 6. Pharmacology and intracellular signaling mechanisms of the native human orphan receptor BRS-3 in lung cancer cells.
    Ryan RR, Weber HC, Mantey SA, Hou W, Hilburger ME, Pradhan TK, Coy DH, Jensen RT.
    J Pharmacol Exp Ther; 1998 Oct 01; 287(1):366-80. PubMed ID: 9765358
    [Abstract] [Full Text] [Related]

  • 7. Rational design of a peptide agonist that interacts selectively with the orphan receptor, bombesin receptor subtype 3.
    Mantey SA, Coy DH, Pradhan TK, Igarashi H, Rizo IM, Shen L, Hou W, Hocart SJ, Jensen RT.
    J Biol Chem; 2001 Mar 23; 276(12):9219-29. PubMed ID: 11112777
    [Abstract] [Full Text] [Related]

  • 8. Comparative pharmacology of bombesin receptor subtype-3, nonpeptide agonist MK-5046, a universal peptide agonist, and peptide antagonist Bantag-1 for human bombesin receptors.
    Moreno P, Mantey SA, Nuche-Berenguer B, Reitman ML, González N, Coy DH, Jensen RT.
    J Pharmacol Exp Ther; 2013 Oct 23; 347(1):100-16. PubMed ID: 23892571
    [Abstract] [Full Text] [Related]

  • 9. Peptide structural requirements for antagonism differ between the two mammalian bombesin receptor subtypes.
    Lin JT, Coy DH, Mantey SA, Jensen RT.
    J Pharmacol Exp Ther; 1995 Oct 23; 275(1):285-95. PubMed ID: 7562561
    [Abstract] [Full Text] [Related]

  • 10. Discovery of a high affinity radioligand for the human orphan receptor, bombesin receptor subtype 3, which demonstrates that it has a unique pharmacology compared with other mammalian bombesin receptors.
    Mantey SA, Weber HC, Sainz E, Akeson M, Ryan RR, Pradhan TK, Searles RP, Spindel ER, Battey JF, Coy DH, Jensen RT.
    J Biol Chem; 1997 Oct 10; 272(41):26062-71. PubMed ID: 9325344
    [Abstract] [Full Text] [Related]

  • 11. Discovery of a novel class of neuromedin B receptor antagonists, substituted somatostatin analogues.
    Orbuch M, Taylor JE, Coy DH, Mrozinski JE, Mantey SA, Battey JF, Moreau JP, Jensen RT.
    Mol Pharmacol; 1993 Oct 10; 44(4):841-50. PubMed ID: 7901752
    [Abstract] [Full Text] [Related]

  • 12. Pharmacology and selectivity of various natural and synthetic bombesin related peptide agonists for human and rat bombesin receptors differs.
    Uehara H, González N, Sancho V, Mantey SA, Nuche-Berenguer B, Pradhan T, Coy DH, Jensen RT.
    Peptides; 2011 Aug 10; 32(8):1685-99. PubMed ID: 21729729
    [Abstract] [Full Text] [Related]

  • 13. The design of a new potent and selective ligand for the orphan bombesin receptor subtype 3 (BRS3).
    Boyle RG, Humphries J, Mitchell T, Showell GA, Apaya R, Iijima H, Shimada H, Arai T, Ueno H, Usui Y, Sakaki T, Wada E, Wada K.
    J Pept Sci; 2005 Mar 10; 11(3):136-41. PubMed ID: 15635635
    [Abstract] [Full Text] [Related]

  • 14. Characterization of bombesin receptors using a novel, potent, radiolabeled antagonist that distinguishes bombesin receptor subtypes.
    Mantey S, Frucht H, Coy DH, Jensen RT.
    Mol Pharmacol; 1993 May 10; 43(5):762-74. PubMed ID: 7684815
    [Abstract] [Full Text] [Related]

  • 15. Internalization of the gastrin-releasing peptide receptor is mediated by both phospholipase C-dependent and -independent processes.
    Benya RV, Akeson M, Mrozinski J, Jensen RT, Battey JF.
    Mol Pharmacol; 1994 Sep 10; 46(3):495-501. PubMed ID: 7935330
    [Abstract] [Full Text] [Related]

  • 16. Neuromedin B receptors retain functional expression when transfected into BALB 3T3 fibroblasts: analysis of binding, kinetics, stoichiometry, modulation by guanine nucleotide-binding proteins, and signal transduction and comparison with natively expressed receptors.
    Benya RV, Wada E, Battey JF, Fathi Z, Wang LH, Mantey SA, Coy DH, Jensen RT.
    Mol Pharmacol; 1992 Dec 10; 42(6):1058-68. PubMed ID: 1336112
    [Abstract] [Full Text] [Related]

  • 17. Expression and characterization of cloned human bombesin receptors.
    Benya RV, Kusui T, Pradhan TK, Battey JF, Jensen RT.
    Mol Pharmacol; 1995 Jan 10; 47(1):10-20. PubMed ID: 7838118
    [Abstract] [Full Text] [Related]

  • 18. Comparative pharmacology of the nonpeptide neuromedin B receptor antagonist PD 168368.
    Ryan RR, Katsuno T, Mantey SA, Pradhan TK, Weber HC, Coy DH, Battey JF, Jensen RT.
    J Pharmacol Exp Ther; 1999 Sep 10; 290(3):1202-11. PubMed ID: 10454496
    [Abstract] [Full Text] [Related]

  • 19. Differential activation of human gastrin-releasing peptide receptor-mediated responses by bombesin analogs.
    Wu JM, Hoang DO, Feldman RI.
    Mol Pharmacol; 1995 Apr 10; 47(4):871-81. PubMed ID: 7723750
    [Abstract] [Full Text] [Related]

  • 20. Identification of key amino acids in the gastrin-releasing peptide receptor (GRPR) responsible for high affinity binding of gastrin-releasing peptide (GRP).
    Nakagawa T, Hocart SJ, Schumann M, Tapia JA, Mantey SA, Coy DH, Tokita K, Katsuno T, Jensen RT.
    Biochem Pharmacol; 2005 Feb 15; 69(4):579-93. PubMed ID: 15670577
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.